# Public Health Conference Support Cooperative Agreement Program for Human Immunodeficiency Virus (HIV) Prevention

> Briefs, arguments, decisions, and more.

URL: https://www.frixlaw.com/law-library/documents/fr%3A97-32867

## Record

- **Collection:** Federal Register
- **Document type:** Notice
- **Published:** December 17, 1997
- **Citation:** 62 FR 66106

## Text

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement Number 802]

Public Health Conference Support Cooperative Agreement Program
for Human Immunodeficiency Virus (HIV) Prevention

Introduction

The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1998 funds for the Public Health
Conference Support Cooperative Agreement Program for Human
Immunodeficiency Virus (HIV) Prevention. CDC is committed to achieving
the health promotion and disease prevention objectives of Healthy
People 2000, a national activity to reduce morbidity and mortality and
improve the quality of life. This announcement is related to the
priority area of HIV Infection. (For ordering a copy of Healthy People
2000 and CDC's Strategic Plan for Preventing Human Immunodeficiency
Virus (HIV) Infection (July 8, 1992), see the section WHERE TO OBTAIN
ADDITIONAL INFORMATION.)

Authority

This program is authorized under Section 317(k)(2) [42 U.S.C.
247b(k)(2)] of the Public Health Service Act, as amended.

Smoke-Free Workplace

CDC strongly encourages all grant recipients to provide a smoke-
free workplace and promote the non-use of all tobacco products, and
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities that receive Federal funds in which education,
library, day care, health care, or early childhood development services
are provided to children.

Eligible Applicants

Eligible applicants are non-profit organizations including
universities, colleges, research institutions, hospitals, other public
and private (e.g., national, regional) non-profit organizations and
federally recognized Indian tribal governments, Indian tribes or Indian
tribal organizations. State and local health departments may only apply
for funding under Category 2 (See Application Section).

Note: Organizations authorized under section 501(c)(4) of the
Internal Revenue Code of 1986 are not eligible to receive Federal
grant/cooperative agreement funds.

Availability of Funds

Approximately $400,000 is available in FY 1998 to fund
approximately 15 to 25 awards. It is expected that the average award
will be $20,000 and will be funded for a 12-month budget and project
period. Funding estimates may vary and are subject to change.

Use of Funds

CDC funds may be used for direct cost expenditures:
salaries, speaker fees, rental of conference related equipment,
registration fees, and transportation cost (not to exceed economy class
fares) for non-Federal employees.
CDC funds may be used for only those parts of the
conference specifically supported by CDC as documented in the Notice of
Cooperative Agreement (award document).
CDC funds may not be used for the purchase of equipment,
payments of honoraria, organizational dues, entertainment or personal
expenses, cost of travel and payment of a Federal

[[Page 66107]]

employee, or per diem or expenses, other than mileage, for local
participants.
CDC funds may not be used for reimbursement of indirect
costs.
CDC funds may not be used to purchase novelty items (e.g.,
bags, T-shirts, hats, pens) distributed at meetings.
CDC will not fund 100 percent of the proposed conference.
Part of the cost of the proposed conference must be supported with
other than Federal funds.
CDC will not fund a conference after it has taken place.
CDC funds may be used for only those parts of the
conference specifically supported by CDC as documented on the notice of
award.

Restrictions on Lobbying

Fiscal year 1997 appropriation lobbying language remains in full
effect as follows: Applicants should be aware of restrictions on the
use of HHS funds for lobbying under the requirements of Section 1352 of
Public Law 101-121, effective December 23, 1989. This law provides, in
pertinent part, that recipients (and their subtier contractors and/or
subgrantees) are prohibited from using appropriated Federal funds
(other than profits from a Federal contract) for lobbying Congress or
any Federal agency in connection with the award of a particular
contract, grant, cooperative agreement or loan. This would include
grants/cooperative agreements that, in whole or in part, involve
conferences for which Federal funds cannot be used directly or
indirectly encouraging participants to lobby or instructing
participants on how to lobby.
Section 503 of the Departments of Labor, Health and Human Services,
and Education, and Related Agencies Appropriations Act (Public Law 104-
208), effective October 1, 1996, establishes additional restrictions on
the use of Federal funds for lobbying. Whereas previous anti-lobbying
prohibitions involved only activities for or against passage of
legislation pending before the Congress, the FY 1997 appropriations
language establishes an additional prohibition against lobbying for or
against legislation pending before State legislatures:
Section 503(a): No part of any appropriation contained in the FY
1997 Appropriations Act shall be used, other than for normal and
recognized executive-legislative relationships, for publicity or
propaganda purposes, for the preparation, distribution, or use of any
kit, pamphlet, booklet, publication, radio, television, or video
presentation designed to support or defeat legislation pending before
the Congress, * * * except in presentation to the Congress itself or
any State legislature.
Section 503(b): No part of any appropriation contained in the Act
shall be used to pay the salary or expenses of any grant or contract
recipient, or agent acting for such recipient, related to any activity
designed to influence legislation or appropriations pending before the
Congress or any State legislature.
Under Section 503, any activity designed to influence action in
regard to a particular piece of pending legislation would be considered
``lobbying.'' That is, Section 503 prohibits lobbying for or against
pending legislation, as well as indirect or ``grass roots'' lobbying
efforts by award recipients that are directed at inducing members of
the public to contact their elected representatives at the Federal or
State levels to urge support of, or opposition to, pending legislative
proposals. As a matter of policy, CDC extends the prohibitions to
lobbying with respect to local legislation and local legislative
bodies.
The new provisions are not intended to prohibit all interaction
with the legislative branch, or to prohibit educational efforts
pertaining to public health. Clearly there are circumstances when it is
advisable and permissible to provide information to the legislative
branch in order to foster implementation of prevention strategies to
promote public health. However, it would not be permissible to
influence, directly or indirectly, a specific piece of pending
legislation.
It remains permissible to use CDC funds to engage in activity to
enhance prevention; collect and analyze data; publish and disseminate
results of research and surveillance data; implement prevention
strategies; conduct community outreach services; provide leadership and
training, and foster safe and healthful environments.
Recipients of CDC grants and cooperative agreements need to be
careful to prevent CDC funds from being used to influence or promote
pending legislation. With respect to conferences, public events,
publications, and ``grassroots'' activities that relate to specific
legislation, recipients of CDC funds should give close attention to
isolating and separating the appropriate use of CDC funds from non-CDC
funds. CDC also cautions recipients of CDC funds to be careful not to
give the appearance that CDC funds are being used to carry out
activities in a manner that is prohibited under Federal law.

Background

The HIV epidemic constitutes a significant threat to the public
health of the United States. The most recent estimate of HIV prevalence
indicates that between 650,000 and 900,000 Americans are living with
HIV. Recently, there has been a marked decrease in deaths among people
with AIDS. The decline in deaths is likely due to both the slowing of
the epidemic and to improved treatments over the past several years.
However, women and people of color are still disproportionately
affected by HIV. Declines in deaths were greater among whites (28
percent) than among blacks (10 percent) and Hispanics (16 percent).
Among women, AIDS deaths declined only 7 percent in the first three
quarters of 1996. HIV/AIDS remains a leading cause of death.
Although the number of AIDS cases in men who have sex with men has
declined, they continue to account for the largest proportion of
reported cases. In 1996, women represented 20 percent of adults and
adolescents reported with AIDS, greater than the proportion in any
previous year. Among women, heterosexual contact and injecting drug use
accounted for 40 percent and 34 percent, respectively, of cases
reported in 1996. For the first time, blacks represented 41 percent of
adults and adolescents reported with AIDS, exceeding the proportion in
the white population.
A great number of public and private health care providers have
made significant strides in developing effective strategies for HIV
information dissemination and prevention. However, mechanisms are
needed to disseminate information about the newest developments in
disease prevention, health promotion techniques, and their practical
applications nationwide.
CDC supports local, State, regional, national, and international
health efforts to prevent unnecessary disease, disability, and
premature death and to improve the quality of life. This support often
takes the form of education, including the transfer of research
findings and public health strategies and practices, through symposia,
seminars, and workshops. Through its support of conferences and
meetings related to the areas of public health research, education, and
prevention applications, CDC is a key participant in the dissemination
of essential prevention information and in the implementation of HIV
prevention programs.

National HIV Prevention Goal

Applications must be consistent with the CDC national goal of
assisting in building and maintaining the necessary

[[Page 66108]]

State, local, and community infrastructure and technical capacity to
carry out necessary HIV and STD prevention programs.

Purpose

The purpose of the HIV Prevention Conference Support funding is to
provide PARTIAL support for specific non-Federal conferences in the
areas of health promotion, disease prevention information and education
programs, and applied research. Because conference support by CDC
creates the appearance of CDC co-sponsorship, there will be active
participation by CDC in the development and approval of those portions
of the agenda supported by CDC funds. CDC funds will not be expended
for non-approved portions of conference. In addition, CDC will reserve
the right to approve or reject the content of the full agenda, press
events, promotional materials (including press releases), speaker
selection, and site selection. Contingency awards will be made allowing
usage of only 25 percent of the total amount to be awarded until a
final full agenda is approved by CDC. This will provide funds to
support costs associated with preparation of the agenda. The remainder
of funds will be released only upon approval of the final full agenda.
CDC reserves the right to terminate co-sponsorship at any time.
This program is not meant for conferences to educate the general
public or to deliver prevention interventions to persons at risk for
HIV infection.
Any conference sponsored by CDC shall be held in
facilities that are fully accessible to the public as required by the
Americans with Disabilities Act Accessibility Guidelines (ADAAG).
Accessibility under ADAAG addresses accommodations for persons with
sensory impairments as well as persons with physical disabilities or
mobility limitations. The Director, or his/her designee, of the CIO(s)
providing funds or approving CDC sponsorship of a conference must
assure that the proposed meeting facilities comply with ADAAG.
The conference organizer(s) may use CDC's name only in
factual publicity for the conference and should understand that CDC
involvement in the conference does not necessarily indicate support for
the organizer's general policies, activities, or products.
Topics concerned with issues and areas other than HIV prevention
should be directed to other public health agencies or in accordance
with the current Federal Register Notice (see Federal Register Notice
803, [61 FR 19296] published on April 29, 1997).

Program Requirements

Development of HIV prevention conferences may require substantial
CDC collaboration and involvement. In conducting activities to achieve
the purpose of this program, the recipient will be responsible for the
activities listed under A. (Recipient Activities) and CDC will be
responsible for the activities listed under B. (CDC Activities).

A. Recipient Activities

1. Manage all activities related to conference content (e.g.,
objectives, topics, participants, session design, workshops, special
exhibits, speakers, fees, agenda composition, printing). Many of these
items may be developed in concert with assigned CDC project personnel.
2. Provide draft copies of the agenda and proposed ancillary
activities to the CDC Grants Management Office for review and comment.
Submit a copy of the final agenda and proposed ancillary activities to
the CDC Grants Management Office for acceptance.
3. Determine and manage all promotional activities (e.g., title,
logo, announcements, mailers, press). CDC must review and approve the
use of any materials with reference to CDC involvement or support.
4. Manage all registration processes with participants, invitees,
and registrants (e.g., travel, reservations, correspondence, conference
materials and hand-outs, badges, registration procedures).
5. Plan, negotiate, and manage conference site arrangements,
including all audio-visual needs.
6. Develop and conduct education and training programs on HIV
prevention.
7. If the proposed conference is or includes a satellite broadcast:
a. Provide individual, on-camera rehearsals for all presenters,
b. Provide at least one full dress rehearsal involving the
moderator, all presenters, equipment, visuals, and practice telephone
calls at least one day before the actual broadcast and as close to the
actual broadcast time as possible,
c. Provide full scripting and Teleprompter use for the moderator
and all presenters,
d. Select a professional moderator.
8. Collaborate with CDC staff in reporting and disseminating
results and relevant HIV prevention and education and training
information to appropriate Federal, State, and local agencies, health-
care providers, HIV/AIDS prevention and service organizations, and the
general public.

B. CDC Activities

1. Provide technical assistance through telephone calls,
correspondence, and site visits in the areas of program agenda
development, implementation, and priority setting related to the
cooperative agreement.
2. Provide scientific collaboration for appropriate aspects of the
program, including selection of speakers, pertinent scientific
information on risk factors for HIV infection, preventive measures, and
program strategies for the prevention of HIV infection.
3. Review draft agendas and the Grants Management Officer will
issue approval or disapproval of the final agenda and proposed
ancillary activities prior to release of restricted funds.
4. Assist in the reporting and dissemination of research results
and relevant HIV prevention education and training information to
appropriate Federal, State, and local agencies, health-care providers,
the scientific community, and HIV/AIDS prevention and service
organizations, and the general public.

Technical Reporting Requirements

An original and two copies of final performance and financial
status reports (reporting actual expenses) are required no later than
90 days after the end of the budget/project period. The performance
report should include: (1) The cooperative agreement number; (2) title
of the conference; (3) name of the principal investigator, program
director or coordinator; (4) name of the organization that conducted
the conference; (5) a copy of the agenda; (6) a list of individuals who
participated in the formally planned sessions of the meeting; (7) a
summarization of the results of the meeting, including a discussion of
the accomplishments related to stated conference objectives; and (8)
the Program Review Panel's report that all written materials have been
reviewed as required (see the section Program Review Panel).
With the prior approval of CDC, copies of proceedings or
publications resulting from the conference may be substituted for the
final performance report, provided they contain the information
requested in items (1) through (8) above.

Application Content

Organizations should submit separate applications in any of the
three following categories:
Category 1: Regional, national, or international conferences for

[[Page 66109]]

individuals or organizations implementing HIV prevention programs or
providing relevant services. The focus will be on information exchange
including lessons learned and successful programs;
Category 2: Local, statewide, or regional conferences providing
information about technology transfer regarding interventions for
effective HIV prevention for a defined population within a specific
locality, State, or multi-state area (State and local health
departments may apply only under Category 2); and
Category 3: Regional, national, or international conferences for
researchers to impart theoretically based or empirically demonstrated
health research with the intention to train health and other
professionals in innovative, enhanced interventions, e.g., newly
emerging science-based interventions for health professionals.

A. Letter Of Intent (LOI)

Applicants must submit an original and two copies of a two-page
typewritten LOI that briefly describes the application category (1, 2,
or 3), title, location, proposed conference dates, purpose, target
population(s) (e.g., youth, women, Men Who Have Sex with Men (MSM),
Injecting Drug Users (IDU), and the intended audience (number and
description)). The LOI must also include the estimated total cost of
the conference, the percentage of the total cost (which must be less
than 100 percent) being requested from CDC, and the relationship of the
conference to CDC Topics of Special Interest (listed below).
Topics of Special Interest
1. Prevention of HIV infection among:
A. Under-served populations (e.g., women of reproductive age,
racial and ethnic minorities)
B. High-risk populations (e.g., men who have sex with men, drug
users, in-school and out-of-school youth, and migrant workers)
C. Populations in special settings (e.g., correctional
institutions)
D. Under-served geographic areas
Preferences may be given to supporting organizations that serve
multiple high-risk populations.
2. Development of HIV prevention strategies with a broad range of
community, regional, or national partners.
Preferences are established to include national priorities, to
ensure a balance of CDC HIV prevention funding, and to address at-risk
populations and geographic areas that are under-served. No preference
will be given to organizations that have received funding in past
years.
LOIs will be reviewed by CDC and an invitation to submit an
application will be made based on:
1. Documented need for the proposed conference,
2. Contribution to the prevention of HIV/AIDS,
3. National HIV prevention priorities based on emerging trends in
the epidemic,
4. The proposed conference's relationship to the CDC determined
topics of special interest,
5. Timing of the conference that will allow for CDC input, and
6. Availability of funds.
Also include the name, mailing address, telephone number, and if
available, fax number and e-mail address of the organization's primary
contact person. Current recipients of CDC HIV funding must provide the
award number and title of the funded programs. No attachments,
booklets, or other documents accompanying the LOI will be considered.
The two page limitation (inclusive of letterhead and signatures), must
be observed or the letter of intent will be returned without review.

B. Final Application

Applicants invited to apply must develop applications in accordance
with PHS Form 5161-1 (OMB Number 0937-0189). Pages must be clearly
numbered, and a complete index to the application and its appendices
must be included. The original and two required copies of the
application must be submitted unstapled and unbound. All material must
be typewritten in unreduced type on 8\1/2\ by 11'' paper, with at least
1'' margins, and printed on one side only. Materials which should be
part of the basic plan should not be in the appendices. Use the
evaluation criteria described below to develop your application. The
body of the application must be limited to 12 pages.
The following information must be included:
1. A project summary cover sheet that includes:
a. Application category (1, 2, or 3),
b. Name of organization,
c. Name of conference,
d. Location of conference,
e. Date (s) of conference,
f. Target population(s) (e.g., youth, women, MSM, IDU),
g. Intended audience and number,
h. Dollar amount requested,
i. Total conference budget.
2. Biographical sketches and job descriptions of the individuals
responsible for planning and coordinating the conference.
3. A Budget Narrative separately identifying and justifying line
items to which the requested Federal funds would be applied.
4. A draft agenda for the proposed conference.
5. Award number and title(s) of funded program(s) for current
recipients of CDC HIV funding. Must not have submitted the same
proposal for review for funding to other parts of CDC.

Evaluation Criteria

Applications will be reviewed and evaluated according to the
following criteria (TOTAL 100 POINTS).
1. Category-specific criterion (20 points):
A. Category 1: Extent to which the applicant provides evidence of
an opportunity for participants and presenters to interact during the
conference.
B. Category 2: Extent to which the applicant relates the specific
connection of the conference content to HIV prevention community
planning priorities and provides a description of need for the proposed
conference.
C. Category 3: Extent to which the applicant demonstrates the
scientific soundness of the technology to be transferred as evidenced
by inclusion in HIV prevention research publications, peer reviewed
journals, or scientific consensus panel review.
The following criteria apply to all applications:
2. Proposed Program and Technical Approach (30 points):
A. The extent to which the applicant's description of the proposed
conference relates to HIV prevention and education, including the
public health need of the proposed conference and the degree to which
the conference can be expected to influence public health practices,
and the extent of the applicant's collaboration with other agencies
serving the intended audience, including local health and education
agencies concerned with HIV prevention.
B. The applicant's description of conference objectives in terms of
quality, specificity, and the feasibility of the conference based on
the operational plan, and the extent to which evaluation mechanisms for
the conference adequately assess increased knowledge, attitudes, and
behaviors of the target participants.
C. The relevance and effectiveness of the proposed agenda in
addressing the chosen HIV prevention and education topic.
D. The degree to which conference activities proposed for CDC
funding

[[Page 66110]]

strictly adhere to the prevention of HIV transmission.
3. Applicant Capability (25 points):
A. The adequacy and commitment of institutional resources to
administer the program for the proposed conference.
B. The adequacy of existing and proposed facilities and resources
for conducting conference activities.
C. The degree to which the applicant has established and used
critical linkages with health and education departments and community
planning groups with the mandate for HIV prevention. Letters of support
(limit of 5) from such agencies addressing related capability and
experience should be included. They must explain how the agency will
work with the applicant to plan the proposed conference. Letters that
do not pertain directly to the proposed conference will not be
considered.
4. Qualifications of Program Personnel (25 points):
A. The qualifications, experience, and commitment of the principal
staff person, and his or her ability to devote adequate time and effort
to provide effective leadership.
B. The competence of associate staff persons, discussion leaders,
and speakers to accomplish conference objectives.
C. The degree to which the application demonstrates that all key
personnel have education and expertise relative to the conference
objectives, are informed about the transmission of HIV, and understand
nationwide information and education efforts currently underway that
may affect, and be affected by, the proposed conference.
5. Budget Justification and Adequacy of Facilities: (not scored)
The proposed budget will be evaluated on the basis of its
reasonableness, concise and clear justification, consistency with the
intended use of cooperative agreement funds, and the extent to which
the applicant documents financial support from other sources.

Executive Order 12372 Review

This program is not subject to the Executive Order 12372 review.

Public Health System Reporting Requirements

This program is not subject to the Public Health System Reporting
Requirements.

Catalog of Federal Domestic Assistance

The Catalog of Federal Domestic Assistance number is 93.941.

Submission Requirements and Deadlines

A. Letter of Intent (LOI)

1. One original and two copies of the LOI must be postmarked by the
following deadline dates in order to be considered. (Facsimiles are not
acceptable.) An invitation to submit an application does not constitute
a commitment to fund.
2. Letter of Intent Due Dates: January 31, 1998.

B. Application

One original and two copies of the invited application must be
submitted on PHS Form 5161-1 (OMB Number 0937-0189) and must be
postmarked by the date specified in the acceptance letter in order to
be considered in the application cycles.
Applications may be accepted by CDC only after the LOI has been
reviewed by CDC and written invitation from CDC has been received by
prospective applicant. Availability of funds may limit the number of
Letters of Intent, regardless of merit, that receive an invitation to
submit an application.

C. Addresses for Submission of Letter of Intent and Invited
Applications

One original and two copies of the Letters of Intent and invited
application must be postmarked on or before the deadline date and
mailed to: Juanita Dangerfield, Grants Management Branch, Procurement
and Grants Office, Centers for Disease Control and Prevention (CDC),
255 East Paces Ferry Road, NE., Mailstop E-15, Atlanta, GA 30305.

D. Deadlines

Letters of Intent and Application shall be considered as meeting
the deadline if they are either:
1. Received on or before the deadline date, or
2. Postmarked on or before the deadline date and received in time
for submission to the independent review group. (Applicants must
request a legibly dated U.S. Postal Service postmark or obtain a
legibly dated receipt from a commercial carrier or the U.S. Postal
Service. Private metered postmarks will not be acceptable as proof of
timely mailing.)

E. Late Applications

Applications that do not meet the criteria in D.1. or D.2. above
are considered late applications and will be returned to the applicant
without review.

Other Requirements

Program Review Panel

Recipients must comply with the document entitled Content of
HIV/AIDS-Related Written Materials, Pictorials, Audiovisuals,
Questionnaires, Survey Instruments, and Educational Sessions in Centers
for Disease Control Assistance Programs (June 1992) (a copy is in the
application kit). To meet the requirements for a Program Review Panel,
recipients are encouraged to use an existing Program Review Panel such
as the one created by the State health department's HIV/AIDS prevention
program. If the recipient forms its own Program Review Panel, at least
one member must also be an employee (or a designated representative) of
an appropriate health or educational agency, consistent with the
Content Guidelines. The names of review panel members must be listed on
the Assurance of Compliance form (CDC Form 0.1113) which is also
included in the application kit.

Use of CDC Name

The conference organizer(s) may use CDC's name only in factual
publicity for the conference, and should understand that CDC
involvement in the conference does not necessarily indicate support for
the organizer's general policies, activities, or products.

Where To Obtain Additional Information

To receive additional written information, call (404) 332-4561. You
will be asked to leave your name, address, and phone number, and refer
to Announcement Number 802. You will receive a complete program
announcement, a list of the relevant ``Healthy People 2000'' HIV
objectives, and the addresses and phone numbers for CDC contact
personnel. CDC will not send application kits by facsimile or express
mail unless the cost for the latter is paid by the addressee.
This and other CDC announcements are also available through the CDC
homepage on the Internet. The address for the CDC homepage is http://
www.cdc.gov.
If you have questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from Ms. Juanita Dangerfield, Grants Management Specialist, Grants
Management Branch, Procurement and Grants Office, Centers for Disease
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Mailstop
E-15, Room 300, Atlanta, GA 30305, telephone (404) 842-6577.
Programmatic technical assistance may

[[Page 66111]]

be obtained from Ms. Linda LaChanse, Program Analyst, Training and
Technical Support Systems Branch, Division of HIV/AIDS Prevention,
National Center for HIV/STD/TB Prevention, Centers for Disease Control
and Prevention (CDC), 1600 Clifton Road, NE., Mailstop E-40, Atlanta,
GA 30333, telephone (404) 639-0964.
Please refer to Announcement Number 802 when requesting
information, submitting your Letter of Intent and submitting the
invited application in response to the announcement.
Potential applicants may obtain a copy of Healthy People 2000 (Full
Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary
Report, Stock No. 017-001-00473-1) through the Superintendent of
Documents, Government Printing Office, Washington, DC 20402-9325,
telephone (202) 512-1800. Single copies of CDC's Strategic Plan for
Preventing Human Immunodeficiency Virus (HIV) Infection (July 8, 1992)
can be obtained by calling the CDC National AIDS Clearinghouse at (800)
458-5231.

Dated: December 11, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-32867 Filed 12-16-97; 8:45 am]
BILLING CODE 4163-18-P

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/fr%3A97-32867. Public record. Not legal advice.